The FDA will hold a 2 day public hearing to obtain input from those interested in FDA’s scope and direction in modernizing regulations, policies, and practices that apply to clinical trials of FDA-regulated products. Anyone interested is strongly encouraged to join and give their input. The 2 day hearing will be held April 23-24, 2012 at FDA White Oak Campus from 8:30am to 4:30pm. There will also be a webcast offered. To read more about the hearing, how to gain access to the webcast, and further visitor information, click here.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Imposter Participants: Fake Participants Causing Real Problems
2025 Holiday Schedule
OHRP’s Proposed Changes to the Federalwide Assurance Form: An Update
The Latest Federal Funding Cuts and Their Impact on Ethical Clinical Research Oversight
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.